Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Vytora Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Vytora Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 13 · Grade B+

Vytora Health

Visit Vytora Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 87 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Vytora Health a bad call — it's best for comparing monthly semaglutide with a prepaid option and named clinical/pharmacy partners. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
85
Supply Reliability
95
87
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
88
Track Record
88
82
CoreAge RxBrief Score 94 · 87Vytora Health

Price, coverage & the tracker

CoreAge RxVytora Health
Brief Score94/100 (A)87/100 (B+)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$179/mo

Three-month option: $447 upfront ($149/mo equivalent).

Full price details

$179/mo; $447 prepaid for 3 months

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Quote needs confirmation

Treatment card: $249/mo; FAQ: $199/mo.

Quarterly figures also disagree; confirm the full charge.

Full price details

Conflicting $249 and $199 monthly quotes; confirm

CoverageUS only; restrictions by state, confirmed at intakeAdvertises all 50 states and DC; product availability varies
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Vytora Health: Semaglutide is $179 monthly or $447 for three months. Tirzepatide prices conflict across the page; get the exact total before paying.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.